TP53 and breast cancer: Consistent with the results in breast cancer, UTP11 knockdown significantly inhibited HCT116 p53+/+ cell growth and migration, as determined by cell viability (Fig. 5A), colony formation (Fig. 5C), and transwell assays (Fig. 5G).